ECM
EDIT icon

Elgethun Capital Management’s Editas Medicine EDIT Stock Holding History

Elgethun Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200
Closed -$3K – 117
2016
Q4 		$3K Buy
+200
New +$3.04K ﹤0.01% 257

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Elgethun Capital Management's EDIT Position: Q1 2017 in Review

Elgethun Capital Management sold out of Editas Medicine (EDIT) in Q1 2017, closing a stake of 200 shares — an estimated $3K sold.

Elgethun Capital Management first reported a position in EDIT in Q4 2016 and held it in 1 quarter. The position peaked at $3K in Q4 2016. 99 funds tracked by Wall St. Rank hold EDIT as of Q1 2017.

  • Elgethun Capital Management reported no remaining Editas Medicine position as of Q1 2017 after selling out during the quarter.
  • Elgethun Capital Management sold 200 Editas Medicine shares in Q1 2017, an estimated $3K.
  • Elgethun Capital Management first reported a position in Editas Medicine in Q4 2016 and held it in 1 quarter.
  • Elgethun Capital Management's Editas Medicine position peaked at $3K in Q4 2016.
  • 99 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2017.

Based on Elgethun Capital Management's 13F filing for Q1 2017, filed 11 May 2017.